Jiangsu Hengrui Medicine
600276.SS
#508
Rank
C$54.93 B
Marketcap
$8.61
Share price
-0.27%
Change (1 day)
4.66%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$0.93 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are C$0.93 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$0.77 B5.7%
2021-12-31C$0.73 B-4.81%
2020-12-31C$0.77 B58.61%
2019-12-31C$0.48 B-5.27%
2018-12-31C$0.51 B26.65%
2017-12-31C$0.40 B43.79%
2016-12-31C$0.28 B15.44%
2015-12-31C$0.24 B39.63%
2014-12-31C$0.17 B76.15%
2013-12-31C$99.21 M37.92%
2012-12-31C$71.93 M1.14%
2011-12-31C$71.12 M11.66%
2010-12-31C$63.7 M23.71%
2009-12-31C$51.49 M24.88%
2008-12-31C$41.23 M-23.8%
2007-12-31C$54.11 M80.43%
2006-12-31C$29.99 M17.35%
2005-12-31C$25.55 M-24.76%
2004-12-31C$33.96 M-60.86%
2003-12-31C$86.78 M15.26%
2002-12-31C$75.29 M8.36%
2001-12-31C$69.49 M